RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP
Who is RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP?
The Quality Use of Respiratory Medicines Group is based within the Woolcock Institute and University of Sydney, Australia. We research a range of facets of respiratory medicine use in primary care including medicine use from the perspective of health care professional and patients.
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Address:
431 GLEBE POINT RD; GLEBE, NSW 2037, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
No Records Found
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP?
- Where is RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP's headquarter?
- What RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP's spending power?
- Does RESPIMEDS-QUALITY USE OF RESPIRATORY MEDICINES GROUP have a presence in the domain it operates in?